These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 32031781

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nanotheranostics for personalized medicine.
    Mura S, Couvreur P.
    Adv Drug Deliv Rev; 2012 Oct; 64(13):1394-416. PubMed ID: 22728642
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
    Ma Y, Huang J, Song S, Chen H, Zhang Z.
    Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics.
    Ang MJY, Chan SY, Goh YY, Luo Z, Lau JW, Liu X.
    Adv Drug Deliv Rev; 2021 Nov; 178():113907. PubMed ID: 34371084
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases.
    Sahoo RK, Singh H, Thakur K, Gupta U, Goyal AK.
    Curr Pharm Des; 2022 Nov; 28(2):91-103. PubMed ID: 34218771
    [Abstract] [Full Text] [Related]

  • 11. Inorganic nanomaterials with rapid clearance for biomedical applications.
    Wang X, Zhong X, Li J, Liu Z, Cheng L.
    Chem Soc Rev; 2021 Aug 07; 50(15):8669-8742. PubMed ID: 34156040
    [Abstract] [Full Text] [Related]

  • 12. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ, Kuddus M, Tabassum H, Ahmad A, Mabood A.
    Curr Drug Metab; 2017 Aug 07; 18(11):983-999. PubMed ID: 28969548
    [Abstract] [Full Text] [Related]

  • 13. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
    Tan YY, Yap PK, Xin Lim GL, Mehta M, Chan Y, Ng SW, Kapoor DN, Negi P, Anand K, Singh SK, Jha NK, Lim LC, Madheswaran T, Satija S, Gupta G, Dua K, Chellappan DK.
    Chem Biol Interact; 2020 Sep 25; 329():109221. PubMed ID: 32768398
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nanotheranostics in evidence based personalized medicine.
    Sharma S.
    Curr Drug Targets; 2014 Sep 25; 15(10):915-30. PubMed ID: 25174340
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.
    Muthu MS, Leong DT, Mei L, Feng SS.
    Theranostics; 2014 Sep 25; 4(6):660-77. PubMed ID: 24723986
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.